NCT00604032

Study to Determine the Phototoxity of Atralin (Tretinoin) Gel, 0.05%

Clinical Evaluation of the Phototoxic Potential of Atralin (Tretinoin) Gel, 0.05%

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Coria Laboratories, Ltd. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To assess the potential of tretnoin gel 0.05% to produce phototoxic reactions, measured as skin reactions 24 and 48 hours after UV radiation of drug on skin.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Atralin (tretinoin) Gel, 0.05%	Assess potential of tretinoin gel, 0.05% to produce phototoxic reactions, measured 24 and 48 hours after UV radiation of drug on the skin.

Timeline

• Start date: 2008-01-01
• Primary completion: 2008-01-01
• Completion: 2008-02-01
• First posted: 2008-01-29
• Last updated: 2008-03-28

Locations

1 site across 1 country: United States